Rose Bengal Photodynamic Antimicrobial Therapy - VisiRose
Alternative Names: RB-PDAT; Rose bengal & photodynamic therapyLatest Information Update: 26 May 2026
At a glance
- Originator Provectus Biopharmaceuticals; University of Miami
- Developer VisiRose
- Class Anti-infectives; Anti-inflammatories; Antiacnes; Antibacterials; Antineoplastics; Antipsoriatics; Antivirals; Benzoates; Eye disorder therapies; Fluoresceins; Halogenated hydrocarbons; Skin disorder therapies; Small molecules; Xanthenes
- Mechanism of Action Reactive oxygen species stimulants; Singlet oxygen stimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Infectious keratitis